バックプロタックは,細菌における標的タンパク質の分解を媒介する
Francesca E Morreale1, Stefan Kleine2, Julia Leodolter1
1Research Institute of Molecular Pathology, Vienna Biocenter, 1030 Vienna, Austria.
Cell
|June 6, 2022
まとめ
研究者は細菌のタンパク質を分解する 細菌タンパク質を標的とするキメラ (BacPROTAC) を開発した. この新しい技術は,標的型タンパク質破壊のためのClpC:ClpPプロテアスを活性化させ,抗生物質の発見のための新しい道を開きます.
科学分野:
- 細菌によるタンパク質分解
- 薬物の発見
- 分子生物学
背景:
- 細菌のタンパク質の分解をターゲットにすることは 薬剤発見の有望な戦略です
- 既存のタンパク質分解を標的とするキメラ (PROTAC) は,真核生物では有効だが,細菌では有効ではない.
- 細菌のClpC:ClpPプロテアゼシステムは,抗菌薬の介入の潜在的な標的である.
研究 の 目的:
- バクテリアのタンパク質分解を標的とするキメラ (BacPROTAC) を開発する.
- ClpC:ClpPプロテアゼを活性化するBacPROTACのメカニズムを調査する.
- 抗生物質の発見のための菌根菌におけるBacPROTACsの in vivoの有効性を実証する.
主な方法:
- ClpC:ClpPプロテアスを標的とする小分子BacPROTACの設計と合成.
- クリオ電子顕微鏡 (cryo-EM) で活性化されたClpCプロテアスを可視化する.
- ミコバクテリアにおける薬剤感受性およびタンパク質分解の測定
主要な成果:
- BacPROTACsはClpC:ClpPプロテアース基板受容体と結合し,新基板を分解させる.
- BacPROTACsはClpCを活性化し,それを休息状態から機能状態に変換します.
- Cryo-EMは,ClpCの活性化と基板の展開の構造的基礎を明らかにしました.
- ミコバクテリアでの in vivo アッセイでは,BacPROTACsの内生タンパク質を選択的に分解する能力が確認されました.
結論:
- BacPROTAC技術は,ClpC:ClpPシステムをハイジャックすることで,細菌のタンパク質をターゲットに分解します.
- このアプローチは 抗生物質の発見と 細菌生物学における 基礎研究のための 汎用的なツールを提供します
- バックプロタックは 治療目的の 細菌分解機構の再プログラムにおける 重要な進歩です
関連する概念動画
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
The Proteasome
9.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.1K
Tail-anchoring of Proteins in the ER Membrane
3.2K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.2K
The Proteasome Structure
999
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
999
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Bacterial Translocation and Protein Secretion
100
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
100


